Kelowna residents battling prostate cancer will have new treatment options and improved diagnostics as the province expands ...

The pivotal AMPLIFY trial aims to support FDA approval of ⁶⁴Cu-SAR-bisPSMA as a best-in-class imaging tool in prostate cancer ...

The aim of this trial is to investigate the ability of 64 Cu-SAR-bisPSMA PET/computed tomography (CT) to detect recurrence of prostate cancer, with evaluation across 2 imaging timepoints, Day 1 (day ...

Inc. reaches a milestone in prostate cancer diagnostics with its clinically validated SUREcore® biopsy needle and coreCARE® ...

Prostate cancer treatment has improved immensely. Many people can be cured and it can become a manageable, if chronic, ...

A prostate cancer diagnosis can feel overwhelming, but the growing number of targeted treatments means patients (and their ...

National guidelines on prostate cancer screening with the PSA test are set by the US Preventive Services Task Force. Marc B. Garnick, the Gorman Brothers Professor of Medicine at Harvard Medical ...

Nuclear medicine specialist Daniela Oprea-Lager has been appointed Professor of Theranostics at the Radboud University ...

Advancements in prostate cancer screening may be contributing to more reported cases, but are men being overdiagnosed?